Drug Rehab Boston – Difference Drug and Alcohol Rehabilitation
Drug Rehab Boston – Difference Drug and Alcohol Rehabilitation – DrugRehabConsulting.com. Drug Rehab Boston offers great residential drug rehabilitation, outpatient drug centers and self help drug rehabs. The main problem that people are concerned about is the cold climate in the winter. This can be harsh in an already stressful rehabilitation program If you need help with any step of your drug addiction recovery go to http Please note: If you are living in Boston that doesn’t necessarily mean that you should only look for Drug Rehab Boston. There are great treatment centers in many US states and our experience shows that a lot of clients have a better success rate doing rehabilitation outside their known environment. It is just easier to quit in a familiar environment. But where should you start you journey. Well we answer tons of questions for you at DrugRehabConsulting.com. Give it a shot check out our Drug Rehab Boston questions or just contact us directly. The more you know the better off you are going to be! Http (Drug Rehab Boston) {Drug Rehab Boston} [Drug Rehab Boston] “Drug Rehab Boston”
German drug firm makes 1st apology for thalidomide
Filed under: drug addiction treatment for women boston
BERLIN (AP) — The German manufacturer of a notorious drug that caused thousands of babies to be born with shortened arms and legs, or no limbs at all, issued its first ever apology Friday — 50 years after pulling the drug off the market. Gruenenthal …
Read more on Boston.com
Irritable bowel syndrome drug gains FDA approval
Filed under: drug addiction treatment for women boston
The US Food and Drug Administration gave the thumbs up Thursday for a new drug to treat chronic constipation that doesn't respond to standard treatments. The drug, Linzess (linaclotide), is also approved to treat irritable bowel syndrome with constipation.
Read more on Boston.com
Medivation's Prostate Cancer Drug Approved by US FDA
Filed under: drug addiction treatment for women boston
Medivation's therapy, approved three months before the scheduled decision date, is designed for patients whose cancer has advanced beyond the prostate even with previous treatments, the Food and Drug Administration said today in a statement. Xtandi …
Read more on Businessweek